MX2020007391A - Nuevo galactosido inhibidor de galectinas. - Google Patents
Nuevo galactosido inhibidor de galectinas.Info
- Publication number
- MX2020007391A MX2020007391A MX2020007391A MX2020007391A MX2020007391A MX 2020007391 A MX2020007391 A MX 2020007391A MX 2020007391 A MX2020007391 A MX 2020007391A MX 2020007391 A MX2020007391 A MX 2020007391A MX 2020007391 A MX2020007391 A MX 2020007391A
- Authority
- MX
- Mexico
- Prior art keywords
- galectins
- formula
- galectin
- sup
- compound
- Prior art date
Links
- 102000007563 Galectins Human genes 0.000 title abstract 2
- 108010046569 Galectins Proteins 0.000 title abstract 2
- 150000008195 galaktosides Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000000795 Galectin 1 Human genes 0.000 abstract 1
- 108010001498 Galectin 1 Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 150000003214 pyranose derivatives Chemical group 0.000 abstract 1
- 125000001425 triazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18150959 | 2018-01-10 | ||
| PCT/EP2019/050467 WO2019137971A1 (en) | 2018-01-10 | 2019-01-09 | Novel galactoside inhibitor of galectins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020007391A true MX2020007391A (es) | 2020-09-03 |
Family
ID=60953765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020007391A MX2020007391A (es) | 2018-01-10 | 2019-01-09 | Nuevo galactosido inhibidor de galectinas. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11046725B2 (https=) |
| EP (1) | EP3737686A1 (https=) |
| JP (1) | JP2021510692A (https=) |
| KR (1) | KR20200108303A (https=) |
| CN (1) | CN111699193A (https=) |
| BR (1) | BR112020013647A2 (https=) |
| CA (1) | CA3086092A1 (https=) |
| EA (1) | EA202091684A1 (https=) |
| MX (1) | MX2020007391A (https=) |
| WO (1) | WO2019137971A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2970062C (en) * | 2015-01-30 | 2023-02-28 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| JP2021510692A (ja) * | 2018-01-10 | 2021-04-30 | ガレクト バイオテック エービー | ガレクチンの新規なガラクトシド阻害剤 |
| JP2022508720A (ja) * | 2018-10-15 | 2022-01-19 | ガレクト バイオテック エービー | ガレクチンのガラクトシド阻害剤 |
| US12291547B2 (en) | 2019-06-14 | 2025-05-06 | UNIVERSITé LAVAL | Synthesis of 3-azido-3-deoxy-D-galactopyranose |
| JP7674276B2 (ja) * | 2019-07-03 | 2025-05-09 | ガレクト バイオテック エービー | ガレクチンの新規なガラクトシド阻害剤 |
| TW202134214A (zh) * | 2020-03-04 | 2021-09-16 | 瑞士商先正達農作物保護公司 | 用於製備具有3-含硫取代基的5-氯-吡啶-2-甲酸醯胺以及甲酸鹽之方法 |
| WO2025180907A1 (en) * | 2024-02-26 | 2025-09-04 | Galecto Biotech Ab | Specific galactoside inhibitor of galectin-1 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6849607B2 (en) | 2001-05-09 | 2005-02-01 | Health Research, Inc. | Galectin recognized photosensitizers for photodynamic therapy |
| SE0401301D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel 3-triazolyl-galactoside inhibitors of galectins |
| SE0401300D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel Galactoside Inhibitors of Galectins |
| ES2652488T3 (es) | 2009-04-28 | 2018-02-02 | Galecto Biotech Ab | Nuevos inhibidores de galactósidos de galectinas |
| DK2906227T3 (en) | 2012-10-10 | 2018-12-10 | Galectin Therapeutics Inc | GALACTOSE-CONTAINING CARBOHYDRATE COMPOUNDS FOR THE TREATMENT OF DIABETIC Nephropathy |
| CN104755088A (zh) | 2012-10-31 | 2015-07-01 | 格莱克特生物技术公司 | 半乳凝集素-3的半乳糖苷抑制剂及其用于治疗肺纤维化的应用 |
| JP6707548B2 (ja) * | 2015-01-16 | 2020-06-10 | ガレクト・バイオテック・エイビイ | ガレクチンの新規なガラクトシド阻害剤 |
| CA2970062C (en) * | 2015-01-30 | 2023-02-28 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| US10988502B2 (en) * | 2016-07-12 | 2021-04-27 | Galecto Biotech Ab | Alpha-D-galactoside inhibitors of galectins |
| CA3025867A1 (en) * | 2016-07-12 | 2018-01-18 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| JP2021510692A (ja) * | 2018-01-10 | 2021-04-30 | ガレクト バイオテック エービー | ガレクチンの新規なガラクトシド阻害剤 |
-
2019
- 2019-01-09 JP JP2020538084A patent/JP2021510692A/ja active Pending
- 2019-01-09 EP EP19700281.9A patent/EP3737686A1/en not_active Withdrawn
- 2019-01-09 WO PCT/EP2019/050467 patent/WO2019137971A1/en not_active Ceased
- 2019-01-09 CA CA3086092A patent/CA3086092A1/en active Pending
- 2019-01-09 US US16/960,996 patent/US11046725B2/en active Active
- 2019-01-09 BR BR112020013647-6A patent/BR112020013647A2/pt not_active Application Discontinuation
- 2019-01-09 KR KR1020207022591A patent/KR20200108303A/ko not_active Withdrawn
- 2019-01-09 EA EA202091684A patent/EA202091684A1/ru unknown
- 2019-01-09 CN CN201980007910.3A patent/CN111699193A/zh active Pending
- 2019-01-09 MX MX2020007391A patent/MX2020007391A/es unknown
-
2021
- 2021-05-24 US US17/327,954 patent/US11827666B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3737686A1 (en) | 2020-11-18 |
| US11827666B2 (en) | 2023-11-28 |
| CA3086092A1 (en) | 2019-07-18 |
| BR112020013647A2 (pt) | 2020-12-01 |
| WO2019137971A1 (en) | 2019-07-18 |
| US20200347089A1 (en) | 2020-11-05 |
| CN111699193A (zh) | 2020-09-22 |
| US11046725B2 (en) | 2021-06-29 |
| US20210284678A1 (en) | 2021-09-16 |
| KR20200108303A (ko) | 2020-09-17 |
| EA202091684A1 (ru) | 2020-12-04 |
| JP2021510692A (ja) | 2021-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020007391A (es) | Nuevo galactosido inhibidor de galectinas. | |
| EP3828191A3 (en) | Novel galactoside inhibitor of galectins | |
| MX2023000025A (es) | Inhibidores de la quinasa progenitora hematopoyética 1 y usos de estos. | |
| EP4234551A3 (en) | Pyridazinones as parp7 inhibitors | |
| MY209340A (en) | Egfr inhibitor for the treatment of cancer | |
| EP4234031A3 (en) | C40-, c28-, and c-32-linked rapamycin analogs as mtor inhibitors | |
| EP2679595A3 (en) | Di-(3-deoxy-3-1H-1,2,3-triazol-1-yl)-[beta]-D-galacto-pyranosyl)sulfane | |
| PH12021550106A1 (en) | Highly purified fucans for the treatment of fibrous adhesions | |
| WO2021011713A8 (en) | Imidazopyrimidines as eed inhibitors and the use thereof | |
| MX2010001565A (es) | Compuestos triazolicos que modulan la actividad de proteina de choque termico (hsp) 90. | |
| MX2009008547A (es) | Compuestos de triazol que son utiles en el tratamiento de trastornos proliferativos tales como cancer. | |
| MY208545A (en) | Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith | |
| MX379513B (es) | Compuestos de aminopurina sustituida, composiciones de estos y métodos de tratamiento con estos. | |
| NZ595206A (en) | Prodrug forms of kinase inhibitors and their use in therapy | |
| UA95298C2 (ru) | Фенилзамещенные гетероарильные производные и их применение в качестве противоопухолевых средств | |
| PT1902037E (pt) | 2,4-diamino-pirimidinas como inibidores de aurora | |
| MY176944A (en) | Substituted pyrimidines for the treatment of diseases such as cancer | |
| EP4371562A3 (en) | 2-quinolone derived inhibitors of bcl6 | |
| MX2012002641A (es) | Inhibidores de cinasa janus (jak). | |
| PH12019500957A1 (en) | Selective inhibitor of exon 20 insertion mutant egfr | |
| MX2010007026A (es) | Derivados de triazoloxadiazoles. | |
| GEP20146138B (en) | Method for treating androgen receptor positive cancers | |
| MX378932B (es) | Triazoles sustituidos y métodos relacionados a estos. | |
| CR20240109A (es) | Malonamidas herbicidas que contienen anillos heteroaromáticos monocíclicos | |
| AU2019328154A8 (en) | Pyrazole compounds, pharmaceutical compositions thereof and use thereof |